Awards

NIH Awards $50 Million to UMass Center for Clinical and Translational Science

By May 27, 2026No Comments

The UMass Center for Clinical and Translational Science (UMCCTS) has been awarded a seven-year, $50 million renewal of its Clinical and Translational Sciences Award, along with an associated K12 Scholar program, from the National Center for Advancing Translational Sciences of the National Institutes of Health.

The UMCCTS was founded in 2006 to enhance clinical and translational research across the five University of Massachusetts campuses and UMass Memorial Health. It has since expanded to include Baystate Health and Lahey Hospital & Medical Center. The consortium was funded by NIH in 2010, with grant renewals in 2015 and 2020.

Katherine Luzuriaga, MD, the UMass Memorial Health Care Chair in Biomedical Research, professor of molecular medicine, pediatrics and medicine, principal investigator and director of the UMCCTS and vice provost for research, said, “We’re grateful for the support from the NIH that has advanced collaboration across the five UMass campuses and our clinical partners. Each partner brings a different set of scientific or clinical expertise to transdisciplinary collaborations that have contributed to the innovation and impact resulting from the grant.”

“Collaboration is really the ethos of this grant. It’s all about figuring out how we can tackle hard problems with teams across several campuses and from different disciplines,” said Nate Hafer, PhD, associate professor of molecular medicine and director of operations for UMCCTS. We’re looking to get the right group of people together, whether it’s for training our undergrad and graduate students or working with community groups. It’s always about the idea of working together and asking how we can move forward together.”